CAR NKT cells offer a promising approach to combating difficult-to-treat solid… – AlKhaleej Today

Reviewed by Emily Henderson, B.Sc.October 13, 2020Natural killer T cells (NKT), a type of immune cell known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy for treating cancer patients.
Researchers at Baylor College of Medicine and the University of North Carolina at Chapel Hill have genetically engineered human NKT cells with a chimeric antigen receptor (CAR) that allows them to specifically recognize neuroblastoma, a form…

Click here to view the original article.